• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Christianacare Partners with Cedar to Personalize Patient Financial Experience

Share:

January 22, 2020

Highlights on this story:
  • ChristianaCare partners with Cedar, a patient engagement and payment technology platform to modernize and personalize the patient financial experience for ChristianaCare patients.
  • Beginning this spring, the new payment experience will be implemented for most ChristianaCare services, including its primary and specialty care, imaging, labs, rehabilitation services and more.

ChristianaCare today announced a new collaboration with Cedar, a patient engagement and payment technology platform that will modernize and personalize the financial experience for ChristianaCare patients. Cedar’s patient engagement and payment platform enables customized outreach, messaging and bill resolution to deliver a personalized experience optimized for each patient.

Optimizing The Patient Financial Experience

Cedar’s The technology uses data and learns from individual user interactions to identify patients who may be eligible for a payment plan or financial assistance, and then it makes those options easily available to navigate.
Beginning this spring, the new payment experience will be implemented for most ChristianaCare services, including its primary and specialty care, imaging, labs, rehabilitation services and more. Key features for ChristianaCare patients include personalized communications, customized payment methods, and real-time customer support.

ChristianaCare includes an extensive network of outpatient services, home healthcare, medical aid units, three hospitals (1,299 beds), Level I trauma center and Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care, and women’s health.

“As we work to make a positive impact on health for everyone, in all of the communities we serve, we are leveraging data and new technologies to communicate with people in ways that are meaningful to them,” said ChristianaCare Chief Communications and Experience Officer Drew Fennell. “This new patient financial experience is another example of how we are transforming care to make it convenient, personal and responsive to the needs and preferences of each patient.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: hit consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Why Companies Need Healthcare Commercial IntelligenceWhy Companies Need Healthcare Commercial Intelligence
  • Active Pharmaceutical Ingredient Market to Hit USD 261.28 Billion and Exhibit 6.1% CAGR by 2026Active Pharmaceutical Ingredient Market to Hit USD 261.28 Billion and Exhibit 6.1% CAGR by 2026
  • Forum Health Acquires Chicago-Area PracticeForum Health Acquires Chicago-Area Practice
  • mRNA Disruptor Goes Public in $1.5 Billion SPAC DealmRNA Disruptor Goes Public in $1.5 Billion SPAC Deal
  • Intuition Robotics Musters $36M Series B for Its Assorted AI CompanionsIntuition Robotics Musters $36M Series B for Its Assorted AI Companions
  • Leading Independent Proxy Advisory Firm ISS Recommends That Centene and WellCare Stockholders Vote “FOR” Proposals Regarding CeLeading Independent Proxy Advisory Firm ISS Recommends That Centene and WellCare Stockholders Vote “FOR” Proposals Regarding Ce
  • An Interview with Todd Unger, Chief Experience Officer of the AMAAn Interview with Todd Unger, Chief Experience Officer of the AMA
  • Covis Group to Acquire AMAG Pharmaceuticals in $647 Million DealCovis Group to Acquire AMAG Pharmaceuticals in $647 Million Deal

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications